ANPEP and neoplasm: Investigating how the tumor-selective targeting of APN/CD13 could be achieved, Curnis et al. observed that the myeloid and epithelial cells, as well as the cancer-related angiogenic blood vessels, express varying subtypes of APN/CD13 [49].